The NTCP p.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect on First-Line Nucleos(t)ide Analog Treatment

Sodium taurocholate cotransporting polypeptide (NTCP) acts as a cellular receptor for the hepatitis B virus infection of host hepatocytes. Previously, many studies confirmed that the NTCP p.Ser267Phe variant was a protective factor against HBV-related disease progression. We therefore designed this...

Full description

Bibliographic Details
Main Authors: Lina Wu, Wenxiong Xu, Xuejun Li, Ying Liu, Lu Wang, Shu Zhu, Fangji Yang, Chan Xie, Liang Peng
Format: Article
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Pharmacology
Online Access: